Vasculogenic mimicry in cancer

Abstract

LI Pi-Song, LI Jian-Yi, ZHANG Wen-Hai. Vasculogenic mimicry in cancer[J]. Journal of International Oncology, 2014, 41(11): 824-827.

［1］ Karroum A, Mirshahi P, Faussat AM, et al. Tubular network formation by adriamycinresistant MCF7 breast cancer cells is closely linked to MMP9 and VEGFR2/VEGFR3 overexpressions［J］. Eur J Pharmacol， 2012, 685(13):17. ［2］ Lee CH, Wu YT, Hsieh HC, et al. Epidermal growth factor/heat shock protein 27 pathway regulates vasculogenic mimicry activity of breast cancer stem/progenitor cel［J］. Biochimie， 2014, 104:117126. ［3］刘见荣，侯风刚. 肿瘤血管生成拟态研究新进展［J］. 现代肿瘤医学， 2013， 21(4):898902. ［4］ Maes H, Van Eygen S, Krysko DV, et al. BNIP3 supports melanoma cell migration and vasculogenic mimicry by orchestrating the actin cytoskeleton［J］. Cell Death Dis， 2014, 5: e1127. ［5］ Yao XH, Ping YF, Bian XW. Contribution of cancer stem cells to tumor vasculogenic mimicry［J］. Protein Cell， 2011, 2(4):266272. ［6］ Lathia JD, Gallagher J, Heddleston JM, et al. Integrin alpha 6 regulates glioblastoma stem cells［J］. Cell Stem Cell， 2010, 6(5):421432. ［7］ Ding YP, Yang XD, Wu Y, et al. Autophagy promotes the survival and development of tumors by participating in the formation of vasculogenic mimicry［J］. Oncol Rep， 2014, 31(5):23212327. ［8］ Mao XG, Xue XY, Wang L, et al. CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia［J］. Neuro Oncol， 2013, 15(7):865879. ［9］ Du J, Sun B, Zhao X, et al. Hypoxia promotes vasculogenic mimicry formation by inducing epithelialmesenchymal transition in ovarian carcinoma［J］. Gynecol Oncol， 2014, 133（3）： 575583. ［10］ Fang M, Peng CW, Liu SP, et al. In vitro invasive pattern of hepatocellular carcinoma cell line HCCLM9 based on threedimensional cell culture and quantum dots molecular imaging［J］. J Huazhong Univ Sci Technolog Med Sci，2013, 33(4):520524. ［11］ Vartanian AA. Signaling pathways in tumor vasculogenic mimicry［J］. Biochemistry (Mosc)， 2012， 77(9):10441055. ［12］ Jana D, Sarkar DK, Ganguly S, et al. Role of Cyclooxygenase 2 (COX2) in Prognosis of Breast Cancer［J］. Indian J Surg Oncol， 2014， 5(1):5965. ［13］ Liu XM，Zhang QP, Mu Y， et al. Clinical significance of vasculogenic mimicry in human gliomas［J］. J Neurooncol, 2011, 105(2):173179. ［14］ Casas E, Kim J, Bendesky A, et al. Snail2 is an essential mediator of Twist1induced epithelial mesenchymal transition and metastasis［J］. Cancer Res， 2011, 71(1):245254. ［15］ Zhu LF, Hu Y, Yang CC, et al. Snail overexpression induces an epithelial to mesenchymal transition and cancer stem celllike properties in SCC9 cells［J］. Lab Invest， 2012, 92(5):744752. ［16］ Sun D, Sun B, Liu T, et al. Slug promoted vasculogenic mimicry in hepatocellular carcinoma［J］. J Cell Mol Med， 2013, 17(8):10381047. ［17］ El Hallani S, Boisselier B, Peglion F, et al. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry［J］. Brain，2010， 133(4):973982. ［18］ Larson AR, Lee CW, Lezcano C, et al. Melanoma spheroid formation involves lamininassociated vasculogenic mimicry［J］. Am J Pathol，2014， 184(1):7178. ［19］ Sher I, Adham SA, Petrik J, et al. Autocrine VEGFA/KDR loop protects epithelial ovarian carcinoma cells from anoikis［J］. Int J Cancer, 2009， 124(3):553561. ［20］张凤梅，李胜水，许华，等. 乳腺癌血管生成拟态及其与VEGF表达相关性的研究［J］. 现代肿瘤医学, 2012， 20(11):23242327. ［21］ Chai DM, Bao ZQ, Hu JG, et al. Vasculogenic mimicry and aberrant expression of HIFlalpha/Ecad are associated with worse prognosis of esophageal squamous cell carcinoma［J］. J Huazhong Univ Sci Technolog Med Sci， 2013, 33(3):385391. ［22］ Misra RM, Bajaj MS， Kale V. Vasculogenic mimicry of HT1080 tumour cells in vivo: critical role of HIF1alphaneuropilin1 axis［J］. PLoS One， 2012， 7(11):e50153. ［23］ Li JY, Zhang Y, Zhang WH, et al. Differential distribution of miR20a and miR20b may underly metastatic heterogeneity of breast cancers［J］. Asian Pac J Cancer Prev， 2012, 13(5):19011906. ［24］ Wang J, Gu Z, Ni P, et al. NFkappaB P50/P65 heterodimer mediates differential regulation of CD166/ALCAM expression via interaction with micoRNA9 after serum deprivation, providing evidence for a novel negative autoregulatory loop［J］. Nucleic Acids Res，2011, 39(15):64406455. ［25］ Song Y, Mu L, Han X, et al. MicroRNA9 inhibits vasculogenic mimicry of glioma cell lines by suppressing Stathmin expression［J］. J Neurooncol，2013, 115(3):381390. ［26］ Wu N, Zhao X, Liu M, et al. Role of microRNA26b in glioma development and its mediated regulation on EphA2［J］. PLoS One， 2011， 6(1):e16264. ［27］ Shevde LA, Metge BJ, Mitra A, et al. Spheroidforming subpopulation of breast cancer cells demonstrates vasculogenic mimicry via hsamiR2995p regulated de novo expression of osteopontin［J］. J Cell Mol Med，2010， 14(6B):16931706. ［28］ Weng C, Dong H, Chen G, et al. miR4093p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin［J］. Cancer Lett， 2012, 323(2):171179.

[1]	Wang Ying, Liu Nan, Guo Bing.Advances of antibody-drug conjugate in the therapy of metastatic breast cancer[J]. Journal of International Oncology, 2024, 51(6): 364-369.
[2]	Sa Qiang, Xu Hangcheng, Wang Jiayu.Advances in immunotherapy for breast cancer[J]. Journal of International Oncology, 2024, 51(4): 227-234.
[3]	Yang Zhi, Lu Yiqiao, Gu Huayan, Ding Jialing, Guo Guilong.Research progress of tumor microenvironment mediated drug resistance in targeted therapy of breast cancer[J]. Journal of International Oncology, 2024, 51(4): 235-238.
[4]	Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190.
[5]	Chen Boguang, Wang Sugui, Zhang Yongjie.Role of serum cholinesterase and inflammatory markers in the prognosis of stage ⅠA -ⅢA breast cancer[J]. Journal of International Oncology, 2024, 51(2): 73-82.
[6]	Gu Huayan, Zhu Teng, Guo Guilong.Breast microbiota and breast cancer： present and future[J]. Journal of International Oncology, 2024, 51(1): 55-58.
[7]	Wang Jing, Xu Wenting.Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526.
[8]	Feng Chengtian, Huang Furong, Cao Shiyu, Wang Jianyu, Nanding Abiyasi, Jiang Yongdong, Zhu Juanying.Relationships between HER2 protein expression and imaging features in HER2 positive breast cancer patients[J]. Journal of International Oncology, 2023, 50(9): 527-531.
[9]	Feng Dongxu, Wu Wei, Gao Pingfa, Wang Jun, Shi Lijuan, Chen Dawei, Li Wenbing, Zhang Meifeng.Effects of miR-451 on glycolysis and apoptosis of breast cancer cells by regulating Rho/ROCK1 pathway[J]. Journal of International Oncology, 2023, 50(8): 449-456.
[10]	Pan Shulan, Liu Chang, He Ping.Effect of fritinib on angiogenesis, tumor growth and IRE1-ASK1-JNK pathway in triple negative breast cancer[J]. Journal of International Oncology, 2023, 50(8): 457-462.
[11]	Wang Wende, Zeng De.Research progress on the mechanism of endocrine therapy resistance for breast cancer[J]. Journal of International Oncology, 2023, 50(6): 352-356.
[12]	Li Qingshan, Xie Xin, Zhang Nan, Liu Shuai.Research progress on the application of combining radiotherapy and systemic therapy in breast cancer[J]. Journal of International Oncology, 2023, 50(6): 362-367.
[13]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207.
[14]	Zhu Jun, Huang Meijin, Li Yuan, Liu Zegang, Xun Xin, Chen Hong.Research progress on targeted therapy of breast cancer with low expression of HER2[J]. Journal of International Oncology, 2023, 50(4): 236-240.
[15]	Zhou Ting, Xu Shaohua, Mei Lin.Efficacy and safety of bevacizumab combined with capecitabine in the treatment of advanced breast cancer[J]. Journal of International Oncology, 2023, 50(3): 144-149.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments